The new platform enables traders to compare prop firms side by side using hundreds of funding rules, account features and trading conditions, making it one of the most comprehensive futures prop firm ...

Scorpio Tankers Inc. (NYSE: STNG) (“Scorpio Tankers,” or the “Company”) announced today that it has issued a redemption notice for its 7.5% Senior Unsecured Notes due 2030 and received a commitment ...

Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a transformative pipeline of induced pluripotent stem cell (iPSC)-derived cellular ...

Lumine Group Inc. (“Lumine Group” or “the Company”) (TSXV: LMN), a global buy-and-hold forever acquirer of communications and media software businesses, today announced that, through its subsidiary, ...

Lumine Group Inc. (“Lumine Group” or “the Company”) (TSXV: LMN), a global buy-and-hold-forever acquirer of communications and media software businesses, today announced the acquisition of Imagine ...

Company to Appoint Mutually Agreed Upon Independent Director; Forms Stockholder Engagement and Clinical and Regulatory Affairs Committees ...

D S Simon Media, a recognized innovator in broadcast public relations and AI search optimization, is celebrating its 40th anniversary on July 4th. "Obviously, a lot has changed during those 40 years, ...

Triller Group Inc. (Nasdaq: ILLR) (“Triller” or the “Company”) today provided an update regarding the capital raising flexibility approved by shareholders at the Company’s Annual Meeting held on June ...

As students across the Northwest begin summer break, PEMCO Mutual Insurance and the Seattle Storm are expanding their commitment to youth literacy with the launch of Power Forward Readers, a ...

Bitcoin (BTC) saw a sharp decline in millionaire addresses during the first half of 2026, according to findings from Finbold’s H1 2026 Cryptocurrency Market Report. Between January 1 and June 30, 2026 ...

Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) and may include paid advertising.

The U.S. Food and Drug Administration today approved Tregzi, the first regulatory T (Treg) cell-based immunotherapy for ...